Is MFC a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Asia as the growth engine, with q1 2026 core eps growth at Up ~11% year over year; verify live figures before acting. The bear case rests on the dominant risk is sensitivity to interest rates and equity markets: as a life insurer with long-dated liabilities and large investment portfolios, Manulife's earnings and book value move with rate changes and market levels, and sharp swings can pressure reported results. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The dominant risk is sensitivity to interest rates and equity markets: as a life insurer with long-dated liabilities and large investment portfolios, Manulife's earnings and book value move with rate changes and market levels, and sharp swings can pressure reported results. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. Walnut is not an investment adviser.

Asia as the growth engine. Asia has become Manulife's fastest-growing region, with Q4 2025 core earnings up about 24% year over year and Q1 2026 up about 22%, alongside strong new-business-value growth.

The dominant risk is sensitivity to interest rates and equity markets: as a life insurer with long-dated liabilities and large investment portfolios, Manulife's earnings and book value move with rate changes and market levels, and sharp swings can pressure reported results. The Global Wealth and Asset Management segment is exposed to net outflows and market-driven fee income, as recent quarters with outflows showed. Legacy blocks such as long-term-care insurance carry long-tail assumption risk around morbidity, mortality, and policyholder behavior. Currency matters too: much of the growth is in Asia and results are reported in Canadian dollars, so foreign-exchange moves affect the numbers, and for US investors the NYSE-listed shares also carry US-dollar translation effects. Insurance is heavily regulated across many jurisdictions, and economic slowdowns can dampen both insurance sales and asset-management flows.

Manulife Financial is one of Canada's largest financial-services companies, offering life insurance, retirement, and wealth and asset-management products across three main geograph

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Asia as the growth engine) stalling in the reported numbers rather than in the narrative, the risk above (the dominant risk is sensitivity to interest rates and equity markets: as a life insurer with long-dated liabilities and large investment portfolios, Manulife's earnings and book value move with rate changes and market levels, and sharp swings can pressure reported results) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

That depends on your goals, time horizon, and risk tolerance, and this is not investment advice. The bull case is a fast-growing Asia franchise, a large global wealth and asset-management arm, and a meaningful, steadily growing dividend backed by strong capital returns. The bear case is sensitivity to interest rates and equity markets, wealth-management outflows in some periods, and legacy long-term-care risk. Many investors hold it for income and stability rather than rapid growth. Weigh both against your portfolio.

Manulife is one of Canada's largest life insurers and a global wealth and asset manager. It sells life insurance, retirement, and investment products across Asia, Canada, and the United States (under the John Hancock brand), and runs a Global Wealth and Asset Management arm that manages money for individuals and institutions. It earns money from insurance premiums and fees, investment spread income, and fees on assets under management.

Manulife shares trade on the New York Stock Exchange under the ticker MFC and on the Toronto Stock Exchange, also as MFC. US investors can buy the NYSE-listed shares through a normal US brokerage account. Because the company reports in Canadian dollars and earns much of its growth in Asia, currency movements can affect the value US investors see.